About Us Services Careers FAQ Contact Us 0
Home Biotechnology Global Organoids and Spheroids Market Share and Forecast to 2031
Organoids and Spheroids Market

Organoids and Spheroids Market Size, Share & Trends Analysis Report By Type (Organoids, Neural Organoids, Hepatic Organoids, Intestinal Organoids), By Spheroids (Multicellular Tumor Spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres , Embryoid bodies), By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity and Efficacy Testing), By End-user (Biotechnology and Pharmaceutical Industries, Academic and Research Institutes, Hospitals and Diagnostic Centers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRBI1267DR
Last Updated : December 27, 2022
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Organoids and Spheroids Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    6. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Organoids
          1. By Value
        3. Neural Organoids
          1. By Value
        4. Hepatic Organoids
          1. By Value
        5. Intestinal Organoids
          1. By Value
      2. By Spheroids
        1. Introduction
          1. Spheroids By Value
        2. Multicellular Tumor Spheroids (MCTS)
          1. By Value
        3. Neurospheres
          1. By Value
        4. Mammospheres
          1. By Value
        5. Hepatospheres 
          1. By Value
        6. Embryoid bodies
          1. By Value
      3. By Application
        1. Introduction
          1. By Application By Value
        2. Developmental Biology
          1. By Value
        3. Personalized Medicine
          1. By Value
        4. Regenerative Medicine
          1. By Value
        5. Disease Pathology Studies
          1. By Value
        6. Drug Toxicity and Efficacy Testing
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Biotechnology and Pharmaceutical Industries
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Hospitals and Diagnostic Centers
          1. By Value
    7. Canada
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    6. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Organoids
          1. By Value
        3. Neural Organoids
          1. By Value
        4. Hepatic Organoids
          1. By Value
        5. Intestinal Organoids
          1. By Value
      2. By Spheroids
        1. Introduction
          1. Spheroids By Value
        2. Multicellular Tumor Spheroids (MCTS)
          1. By Value
        3. Neurospheres
          1. By Value
        4. Mammospheres
          1. By Value
        5. Hepatospheres 
          1. By Value
        6. Embryoid bodies
          1. By Value
      3. By Application
        1. Introduction
          1. By Application By Value
        2. Developmental Biology
          1. By Value
        3. Personalized Medicine
          1. By Value
        4. Regenerative Medicine
          1. By Value
        5. Disease Pathology Studies
          1. By Value
        6. Drug Toxicity and Efficacy Testing
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Biotechnology and Pharmaceutical Industries
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Hospitals and Diagnostic Centers
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    6. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Organoids
          1. By Value
        3. Neural Organoids
          1. By Value
        4. Hepatic Organoids
          1. By Value
        5. Intestinal Organoids
          1. By Value
      2. By Spheroids
        1. Introduction
          1. Spheroids By Value
        2. Multicellular Tumor Spheroids (MCTS)
          1. By Value
        3. Neurospheres
          1. By Value
        4. Mammospheres
          1. By Value
        5. Hepatospheres 
          1. By Value
        6. Embryoid bodies
          1. By Value
      3. By Application
        1. Introduction
          1. By Application By Value
        2. Developmental Biology
          1. By Value
        3. Personalized Medicine
          1. By Value
        4. Regenerative Medicine
          1. By Value
        5. Disease Pathology Studies
          1. By Value
        6. Drug Toxicity and Efficacy Testing
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Biotechnology and Pharmaceutical Industries
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Hospitals and Diagnostic Centers
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    6. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Organoids
          1. By Value
        3. Neural Organoids
          1. By Value
        4. Hepatic Organoids
          1. By Value
        5. Intestinal Organoids
          1. By Value
      2. By Spheroids
        1. Introduction
          1. Spheroids By Value
        2. Multicellular Tumor Spheroids (MCTS)
          1. By Value
        3. Neurospheres
          1. By Value
        4. Mammospheres
          1. By Value
        5. Hepatospheres 
          1. By Value
        6. Embryoid bodies
          1. By Value
      3. By Application
        1. Introduction
          1. By Application By Value
        2. Developmental Biology
          1. By Value
        3. Personalized Medicine
          1. By Value
        4. Regenerative Medicine
          1. By Value
        5. Disease Pathology Studies
          1. By Value
        6. Drug Toxicity and Efficacy Testing
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Biotechnology and Pharmaceutical Industries
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Hospitals and Diagnostic Centers
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Organoids
        1. By Value
      3. Neural Organoids
        1. By Value
      4. Hepatic Organoids
        1. By Value
      5. Intestinal Organoids
        1. By Value
    3. By Spheroids
      1. Introduction
        1. Spheroids By Value
      2. Multicellular Tumor Spheroids (MCTS)
        1. By Value
      3. Neurospheres
        1. By Value
      4. Mammospheres
        1. By Value
      5. Hepatospheres 
        1. By Value
      6. Embryoid bodies
        1. By Value
    4. By Application
      1. Introduction
        1. By Application By Value
      2. Developmental Biology
        1. By Value
      3. Personalized Medicine
        1. By Value
      4. Regenerative Medicine
        1. By Value
      5. Disease Pathology Studies
        1. By Value
      6. Drug Toxicity and Efficacy Testing
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Biotechnology and Pharmaceutical Industries
        1. By Value
      3. Academic and Research Institutes
        1. By Value
      4. Hospitals and Diagnostic Centers
        1. By Value
    6. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Organoids
          1. By Value
        3. Neural Organoids
          1. By Value
        4. Hepatic Organoids
          1. By Value
        5. Intestinal Organoids
          1. By Value
      2. By Spheroids
        1. Introduction
          1. Spheroids By Value
        2. Multicellular Tumor Spheroids (MCTS)
          1. By Value
        3. Neurospheres
          1. By Value
        4. Mammospheres
          1. By Value
        5. Hepatospheres 
          1. By Value
        6. Embryoid bodies
          1. By Value
      3. By Application
        1. Introduction
          1. By Application By Value
        2. Developmental Biology
          1. By Value
        3. Personalized Medicine
          1. By Value
        4. Regenerative Medicine
          1. By Value
        5. Disease Pathology Studies
          1. By Value
        6. Drug Toxicity and Efficacy Testing
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Biotechnology and Pharmaceutical Industries
          1. By Value
        3. Academic and Research Institutes
          1. By Value
        4. Hospitals and Diagnostic Centers
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Organoids and Spheroids Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. 3D Biomatrix (The U.S.)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. 3D Biotek LLC (The U.S.)
    3. AMS Biotechnology (Europe) Limited (U.K.)
    4. ATCC (The U.S.)
    5. Cellesce Ltd.
    6. Corning Incorporated (The U.S.)
    7. Greiner Bio-One (The U.S.)
    8. Hubrecht Organoid Technology (HUB) (the Netherlands)
    9. Kuraray (Japan)
    10. Lonza (Japan)
    11. Merck KGaA (The U.S.)
    12. Thermo Fisher Scientific, Inc. (The U.S.)
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
Buy Now
Global Report
The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
Buy Now
Global Report
Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
Buy Now
Global Report
Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
Buy Now
Global Report
Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.